T396-1034 Screening compound: N-[6-(3-cyclohexyl-2-oxoimidazolidin-1-yl)pyridin-3-yl]-4-(2-oxopyrrolidin-1-yl)benzamide

T396-1034 Screening compound: N-[6-(3-cyclohexyl-2-oxoimidazolidin-1-yl)pyridin-3-yl]-4-(2-oxopyrrolidin-1-yl)benzamide
T396-1034 Screening compound: N-[6-(3-cyclohexyl-2-oxoimidazolidin-1-yl)pyridin-3-yl]-4-(2-oxopyrrolidin-1-yl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T396-1034
N-[6-(3-cyclohexyl-2-oxoimidazolidin-1-yl)pyridin-3-yl]-4-(2-oxopyrrolidin-1-yl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T396-1034

Molecular Formula

C25H29N5O3 (C25 H29 N5 O3)

Compound Name

N-[6-(3-cyclohexyl-2-oxoimidazolidin-1-yl)pyridin-3-yl]-4-(2-oxopyrrolidin-1-yl)benzamide

IUPAC name

N-[6-(3-cyclohexyl-2-oxoimidazolidin-1-yl)pyridin-3-yl]-4-(2-oxopyrrolidin-1-yl)benzamide

SMILES

O=C(c(cc1)ccc1N(CCC1)C1=O)Nc(cc1)cnc1N(CCN1C2CCCCC2)C1=O

InChI

InChI=1S/C25H29N5O3/c31-23-7-4-14-28(23)21-11-8-18(9-12-21)24(32)27-19-10-13-22(26-17-19)30-16-15-29(25(30)33)20-5-2-1-3-6-20/h8-13,17,20H,1-7,14-16H2,(H,27,32)

InChI Key

VKXUHMFTBPZQLN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29023571

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

447.54

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.094

Distribution Coefficient, logD

4.094

Water Solubility, LogSw

-4.05

Polar Surface Area

68.059

Acid Dissociation Constant (pKa)

10.39

Base Dissociation Constant (pKb)

2.71

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.00

T396-1034 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with T396-1034 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T396-1034?
Check Price and Availability of T396-1034, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T396-1034 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T396-1034
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T396-1034
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T396-1034 available by request